$PLX
Protalix BioTherapeutics, Inc. Common Stock
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is PLX up today? It is at $2.38 (+0.00%), and our scanner flagged it 24 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PLX spikes, and full due diligence on PLX — key stats, earnings, dilution and insider activity. Free.
Get free $PLX alerts the moment volume spikes
Our scanner flagged $PLX 24 times in the last 30 days. Create a free account to track $PLX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.38
- Change today
- +0.00%
- Previous close
- $2.38
- 52-week range
- $1.52 – $3.19
- Market cap
- $192M
- Shares outstanding
- 80.6M SEC · as of 2026-08-01 · 22d
- Institutional own.
- 18.61%
- Total held
- 25.2%
- Tradeable float
- 60.3M 75% of shares · after 7% insiders + 19% institutions
- Short interest
- 3.9M ▲ +4% vs prior · as of 2026-07-31
- Short % of float
- 6.4%
- Days to cover
- 7.5d
- Avg daily volume
- 869K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XASE
- 5m
- 0.0x
- 15m
- 0.5x
- 1h
- 0.5x
- 1D
- --
Get free PLX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $PLX moving today?
Here is the latest on PLX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PLX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystProtalix BioTherapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
2 open-market buys0 buys, 0 sells last 3 months (10/1 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bashan Dror Officer | Bought (open market) | +56K 0.07% of company | added 42% | 189K | $101K at $1.81 | Dec 19, 25 |
Bar-Shalev Amos Director | Sold (automatic/other) | -168 | n/a | n/a | $314 at $1.87 | Nov 18, 25 |
Bashan Dror Officer | Acquired (grant/award) | +195K 0.2% of company | added 9.1% | 2.34M | n/a | Sep 3, 25 |
Ben Zvi Shmuel Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Bar-Shalev Amos Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Naos Yaron Officer | Acquired (grant/award) | +25K 0.03% of company | added 12% | 226K | n/a | Sep 3, 25 |
Elze Christian Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Melincoff Gwen A Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Schwartz Aharon Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Boudes Pol F Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Forster Eliot Director | Acquired (grant/award) | +8K | n/a | 8K | n/a | Sep 3, 25 |
Schwartz Aharon Director | Bought (open market) | +129K 0.2% of company | added 74% | 303K | $206K at $1.60 | Jun 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $PLX. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$PLX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$PLX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to PLX
Comparable names in biological products, (no diagnostic substances), closest in size first.
PLX stock FAQ
Why is $PLX moving today?
Here is the latest on PLX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PLX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the PLX stock price today?
PLX last traded at $2.38, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live PLX alerts?
The PLX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PLX 24 times in the last 30 days.
What exchange is PLX on?
PLX (Protalix BioTherapeutics, Inc. Common Stock) trades on XASE, with a market cap of about $192M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is PLX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PLX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.